DNA Script raised €142M in a Series C round in Oct 2021. The company is based in Paris, France. Investors in the round: Farallon Capital, Agilent Technologies, Alexandria Venture Investments and 11 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
